Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Butanethiol | HCID 8012 | — |
| Reactant | HCID 67880269 | HCID 67880269 | — |
| Product | HCID 86738656 | HCID 86738656 | 81.8% |
Reaction Steps
A solution of 11β-acetyloxy-17-(ethylthio)-9-fluoroandrosta-1,4,16-triene-3-one (700 mg; see example 11c) and n-butanethiol (271 mg) is cooled and stirred in a bath at -40° to -45° C. and distilled boron trifluoride etherate (0.3 ml) is added. After 2.0 hours at -40° to -45° C., the solution is gradually warmed to 10° C. in the course of 1.5 hours. The mixture is then diluted with dichloromethane, washed successively with a saturated sodium bicarbonate solution and brine, dried (MgSO4 anh.) and is evaporated to afford the crude title compound. This material is chromatographed over a column of silica gel (20 g), eluting the column with chloroform-hexane mixtures (1:1, 1:4), chloroform and chloroform-ethyl acetate (95:5) to afford the title compound (700 mg). Examination of the nmr spectrum and tlc behavior shows that this material is contaminated with a significant amount of the starting steriod which is not readily separable from the more polar isomer of the product under the tlc systems examined. Partial separation of the two 17-isomers is achieved under these tlc conditions.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04361559 |
|---|
| Source dataset | uspto-grants-1982_11 |
|---|
| ORD ID | ord-56b917da08f145f2900b85bd392c369a |
|---|
| Source note | uspto-grants-1982_11 |
|---|